berberine has been researched along with Leishmaniasis, Mucocutaneous in 1 studies
Leishmaniasis, Mucocutaneous: A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " donovani but was not as potent as meglumine antimonate (Glucantime), a standard drug for the treatment of leishmaniasis." | 3.68 | Berberine derivatives as antileishmanial drugs. ( Hanson, WL; Klayman, DL; Lovelace, JK; Vennerstrom, JL; Waits, VB, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vennerstrom, JL | 1 |
| Lovelace, JK | 1 |
| Waits, VB | 1 |
| Hanson, WL | 1 |
| Klayman, DL | 1 |
1 other study available for berberine and Leishmaniasis, Mucocutaneous
| Article | Year |
|---|---|
Berberine derivatives as antileishmanial drugs.
Topics: Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Body Weight; Cricetinae; Leishmaniasi | 1990 |